BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 24515922)

  • 1. Mesenchymal stem cell trials for pulmonary diseases.
    Antunes MA; Laffey JG; Pelosi P; Rocco PR
    J Cell Biochem; 2014 Jun; 115(6):1023-32. PubMed ID: 24515922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell therapy for acute respiratory distress syndrome: a promising future?
    Horie S; Masterson C; Devaney J; Laffey JG
    Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell therapy in lung disorders: pathogenesis of lung diseases and mechanism of action of mesenchymal stem cell.
    Inamdar AC; Inamdar AA
    Exp Lung Res; 2013 Oct; 39(8):315-27. PubMed ID: 23992090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells and the lung.
    Sinclair K; Yerkovich ST; Chambers DC
    Respirology; 2013 Apr; 18(3):397-411. PubMed ID: 23316733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
    Conese M; Carbone A; Castellani S; Di Gioia S
    Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-based therapies for the acute respiratory distress syndrome.
    Maron-Gutierrez T; Laffey JG; Pelosi P; Rocco PR
    Curr Opin Crit Care; 2014 Feb; 20(1):122-31. PubMed ID: 24300620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cells for therapeutic applications in pulmonary medicine.
    Stabler CT; Lecht S; Lazarovici P; Lelkes PI
    Br Med Bull; 2015 Sep; 115(1):45-56. PubMed ID: 26063231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of microenvironment in mesenchymal stem cell-based regeneration of intervertebral disc.
    Huang YC; Leung VY; Lu WW; Luk KD
    Spine J; 2013 Mar; 13(3):352-62. PubMed ID: 23340343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Trials With Mesenchymal Stem Cells: An Update.
    Squillaro T; Peluso G; Galderisi U
    Cell Transplant; 2016; 25(5):829-48. PubMed ID: 26423725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells and inflammatory lung diseases.
    Iyer SS; Co C; Rojas M
    Panminerva Med; 2009 Mar; 51(1):5-16. PubMed ID: 19352305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli-induced acute lung injury in mice.
    Shalaby SM; El-Shal AS; Abd-Allah SH; Selim AO; Selim SA; Gouda ZA; Abd El Motteleb DM; Zanfaly HE; El-Assar HM; Abdelazim S
    Cytotherapy; 2014 Jun; 16(6):764-75. PubMed ID: 24525173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases.
    Monsel A; Zhu YG; Gudapati V; Lim H; Lee JW
    Expert Opin Biol Ther; 2016 Jul; 16(7):859-71. PubMed ID: 27011289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
    Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
    Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of mesenchymal stem cell-based therapeutic approaches for cancer - From cells to ghosts.
    Mohr A; Zwacka R
    Cancer Lett; 2018 Feb; 414():239-249. PubMed ID: 29175461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of cell-based therapy in lung diseases.
    Huleihel L; Levine M; Rojas M
    Expert Opin Biol Ther; 2013 Oct; 13(10):1429-40. PubMed ID: 23984902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of products derived from mesenchymal stem/stromal cells in pulmonary disease.
    Mohammadipoor A; Antebi B; Batchinsky AI; Cancio LC
    Respir Res; 2018 Nov; 19(1):218. PubMed ID: 30413158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats.
    Zhao Y; Yang C; Wang H; Li H; Du J; Gu W; Jiang J
    Int Immunopharmacol; 2013 Feb; 15(2):246-53. PubMed ID: 23273653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases.
    Sadeghian Chaleshtori S; Mokhber Dezfouli MR; Jabbari Fakhr M
    Respir Res; 2020 May; 21(1):110. PubMed ID: 32393278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of mesenchymal stromal cells in treatment of lung disorders.
    Kardia E; Zakaria N; Sarmiza Abdul Halim NS; Widera D; Yahaya BH
    Regen Med; 2017 Mar; 12(2):203-216. PubMed ID: 28244823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.